Reduced Expression of Bcl-2 in CD8+ T Cells Deficient in the IL-15 Receptor α-Chain
- 15 January 2002
- journal article
- Published by The American Association of Immunologists in The Journal of Immunology
- Vol. 168 (2), 705-712
- https://doi.org/10.4049/jimmunol.168.2.705
Abstract
Mice that lack IL-15 or the IL-15R alpha-chain (IL-15Ralpha) are deficient in peripheral CD8(+), but not in CD4(+), T cells. This CD8(+) T cell-specific deficiency has now been investigated further by characterization of a new strain of IL-15Ralpha(-/-) mice. The adult mutant mice exhibited a specific reduction in the percentage of CD8-single positive TCR(high) thymocytes. The expression of Bcl-2 was reduced in both CD8(+) thymocytes and naive T cells of the mutant animals, and the susceptibility of these cells to death was increased. Memory CD8(+) cells were profoundly deficient in IL-15Ralpha(-/-)mice, and the residual memory-like CD8(+) cells contained a high percentage of dead cells and failed to up-regulate Bcl-2 expression compared with naive CD8(+) cells. Moreover, exogenous IL-15 both up-regulated the level of Bcl-2 in and reduced the death rate of wild-type and mutant CD8(+) T cells activated in vitro. These results indicate that IL-15 and IL-15Ralpha regulate the expression of Bcl-2 in CD8(+) T cells at all developmental stages. The reduced Bcl-2 content in CD8(+) cells might result in survival defect and contribute to the reduction of CD8(+) cells in IL-15Ralpha(-/-)mice.Keywords
This publication has 32 references indexed in Scilit:
- IL-15/IL-15Rα intracellular trafficking in human melanoma cells and signal transduction through the IL-15RαOncogene, 2000
- Control of Homeostasis of CD8 + Memory T Cells by Opposing CytokinesScience, 2000
- Bcl-2 Rescues T Lymphopoiesis, but Not B or NK Cell Development, in Common γ Chain–Deficient MiceImmunity, 1997
- Bcl-2 Rescues T Lymphopoiesis in Interleukin-7 Receptor–Deficient MiceCell, 1997
- Early lymphocyte expansion is severely impaired in interleukin 7 receptor-deficient mice.The Journal of Experimental Medicine, 1994
- Interleukin (IL) 15 is a novel cytokine that activates human natural killer cells via components of the IL-2 receptor.The Journal of Experimental Medicine, 1994
- Cloning of a T Cell Growth Factor that Interacts with the β Chain of the Interleukin-2 ReceptorScience, 1994
- Positive selection of lymphocytesCell, 1994
- The IL-2 Receptor Complex: Its Structure, Function, and Target GenesAnnual Review of Immunology, 1993
- bcl-2 inhibits multiple forms of apoptosis but not negative selection in thymocytesCell, 1991